• aTyr Pharma Presents Preclinical Data for NRP2-Targeting Antibody ATYR2810 at the American Association for Cancer Research (AACR) ... GlobeNewswire Tue, 29 Apr 2025 23:21:51 GMT
• Promising Potential of aTyr Pharma’s ATYR2810 in Glioblastoma Treatment: Analyst Recommends Buy TipRanks Tue, 29 Apr 2025 20:57:43 GMT
• When Will aTyr Pharma, Inc. (NASDAQ:ATYR) Turn A Profit? Yahoo Finance Tue, 29 Apr 2025 18:33:21 GMT
• aTyr Pharma (ATYR) Reveals Promising Preclinical Data on Cancer Treatment | ATYR Stock News GuruFocus Tue, 29 Apr 2025 13:52:30 GMT
• Breakthrough: Novel Antibody ATYR2810 Extends Survival in Aggressive Brain Cancer Trial Stock Titan Tue, 29 Apr 2025 12:00:00 GMT
• aTyr Pharma Inc expected to post a loss of 19 cents a share - Earnings Preview TradingView Mon, 28 Apr 2025 11:35:06 GMT
• Cantor Fitzgerald maintains Overweight on aTyr Pharma stock By Investing.com Investing.com Nigeria Thu, 24 Apr 2025 07:27:35 GMT
• Cantor Fitzgerald maintains Overweight on aTyr Pharma stock Investing.com Wed, 23 Apr 2025 07:00:00 GMT
• RNA Therapeutics Market Generated Opportunities, Future Scope openPR.com Mon, 21 Apr 2025 14:27:00 GMT
• Cantor maintains Overweight on aTyr Pharma stock ahead of trials By Investing.com Investing.com UK Mon, 21 Apr 2025 07:00:00 GMT
• A gentle approach offers new hope for inflammatory lung diseases EurekAlert! Mon, 07 Apr 2025 07:00:00 GMT
• Breakthrough protein offers new hope for pulmonary sarcoidosis treatment News-Medical Mon, 07 Apr 2025 07:00:00 GMT
• aTyr Pharma to Participate in April Investor Conferences GlobeNewswire Thu, 03 Apr 2025 07:00:00 GMT
• Biotech Innovator aTyr Pharma Sets Key Investor Meetings at Premier Healthcare Conferences Stock Titan Thu, 03 Apr 2025 07:00:00 GMT
• charles schwab investment management inc. takes position in atyr pharma inc (nasdaq:atyr) Defense World Wed, 02 Apr 2025 08:13:32 GMT
• ATyr Pharma : ClearOne, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results marketscreener.com Wed, 02 Apr 2025 05:18:21 GMT
• Scleroderma Pipeline: Pioneering Progress with 40+ Leading openPR.com Mon, 31 Mar 2025 07:00:00 GMT
• confident buy rating for atyr pharma amidst promising phase 3 study insights TipRanks Fri, 28 Mar 2025 18:09:22 GMT
• atyr pharma announces inducement grants under nasdaq listing rule 5635(c)(4) The Manila Times Fri, 28 Mar 2025 07:00:00 GMT
• aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Thu, 27 Mar 2025 07:00:00 GMT
• aTyr Pharma Strengthens Drug Development Team with New Equity Compensation Package Stock Titan Thu, 27 Mar 2025 07:00:00 GMT
• Is aTyr Pharma (ATYR) The Hot Biotech Stock Under $5? Insider Monkey Thu, 27 Mar 2025 07:00:00 GMT
• confident buy rating for atyr pharma amidst promising phase 3 study insights TipRanks Thu, 27 Mar 2025 07:00:00 GMT
• ATyr hires ex-ChemoCentryx commercial chief for planned launch Fierce Pharma Wed, 26 Mar 2025 07:00:00 GMT
• aTyr Pharma Announces the Appointment of Dalia R. Rayes as Head of Commercial, Global Efzofitimod Franchise GlobeNewswire Wed, 26 Mar 2025 07:00:00 GMT
• 25-year pharma veteran joins atyr to launch first new sarcoidosis treatment in 70 years Stock Titan Wed, 26 Mar 2025 07:00:00 GMT
• victory capital management inc. buys new stake in atyr pharma inc (nasdaq:atyr) Defense World Mon, 24 Mar 2025 07:00:00 GMT
• insider buying: jane gross acquires additional shares of atyr ph GuruFocus.com Sat, 22 Mar 2025 07:57:06 GMT
• Insider Buying: Jane Gross Acquires Additional Shares of aTyr Pharma Inc (ATYR) GuruFocus Fri, 21 Mar 2025 07:00:00 GMT
• Is aTyr Pharma (ATYR) Stock Outpacing Its Medical Peers This Year? Nasdaq Wed, 19 Mar 2025 07:00:00 GMT
• Atyr, FDA align on efzofitimod trial analysis for pulmonary sarcoidosis Sarcoidosis News Tue, 18 Mar 2025 07:00:00 GMT
• aTyr Pharma (ATYR) Stock Soars 24% on Promising Drug Developments TipRanks Mon, 17 Mar 2025 07:00:00 GMT
• buy rating affirmed for atyr pharma amid strategic trial adjustments and financial stability TipRanks Mon, 17 Mar 2025 06:57:40 GMT
• reviewing atyr pharma (nasdaq:atyr) & windtree therapeutics (nasdaq:wint) Defense World Mon, 17 Mar 2025 05:27:34 GMT
• hc wainwright reaffirms buy rating for atyr pharma (nasdaq:atyr) Defense World Sun, 16 Mar 2025 08:37:50 GMT
• buy rating affirmed for atyr pharma amid strategic trial adjustments and financial stability TipRanks Sun, 16 Mar 2025 07:00:00 GMT
• atyr pharma inc (nasdaq:atyr) receives average recommendation of “buy” from brokerages Defense World Sat, 15 Mar 2025 07:00:00 GMT
• atyr pharma’s earnings call highlights progress and challenges TipRanks Sat, 15 Mar 2025 00:30:15 GMT
• aTyr Pharma: Good Safety Data In Pulmonary Sarcoidosis, Institutions Are Accumulating Seeking Alpha Fri, 14 Mar 2025 07:00:00 GMT
• aTyr Pharma Inc (ATYR) Q4 2024 Earnings Call Highlights: Strong Cash Position and Promising ... Yahoo Finance Fri, 14 Mar 2025 07:00:00 GMT
• aTyr Pharma’s Earnings Call Highlights Progress and Challenges TipRanks Fri, 14 Mar 2025 07:00:00 GMT
• h.c. wainwright maintains $35 target on atyr pharma stock Investing.com Fri, 14 Mar 2025 07:00:00 GMT
• cantor fitzgerald maintains overweight on atyr pharma stock Investing.com Fri, 14 Mar 2025 07:00:00 GMT
• atyr pharma shares fall as q4 loss narrows by investing.com Investing.com India Fri, 14 Mar 2025 07:00:00 GMT
• atyr pharma announces fourth quarter and full year 2024 results and provides corporate update The Manila Times Fri, 14 Mar 2025 07:00:00 GMT
• strategic adjustments and promising developments lead to buy rating for atyr pharma TipRanks Fri, 14 Mar 2025 07:00:00 GMT
• atyr pharma earnings results: $atyr reports quarterly earnings Nasdaq Thu, 13 Mar 2025 20:30:00 GMT
• aTyr Pharma Hits Major Phase 3 Milestone with $94M War Chest for Sarcoidosis Drug Stock Titan Thu, 13 Mar 2025 07:00:00 GMT
• aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update GlobeNewswire Thu, 13 Mar 2025 07:00:00 GMT
• aTyr Pharma Inc Reports Q4 2024 Earnings: EPS of -$0.18 Beats Es GuruFocus Thu, 13 Mar 2025 07:00:00 GMT
• After-Hours Earnings Report for March 13, 2025 : WPM, DOCU, ULTA, SMTC, EVCM, PD, KRT, EGY, XPOF, ALLO, ATYR, RGNX Nasdaq Thu, 13 Mar 2025 07:00:00 GMT
• aTyr Pharma Inc reports results for the quarter ended December 31 - Earnings Summary TradingView Thu, 13 Mar 2025 07:00:00 GMT
• aTyr Pharma Announces Publication Demonstrating Efzofitimod's Immunomodulatory Activity in Science Translational Medicine The Manila Times Thu, 13 Mar 2025 07:00:00 GMT
• earnings call transcript: atyr pharma q4 2024 beats eps expectations Investing.com Thu, 13 Mar 2025 07:00:00 GMT
• atyr pharma shares fall as q4 loss narrows by investing.com Investing.com UK Thu, 13 Mar 2025 07:00:00 GMT
• Breakthrough: New Science Study Reveals How Efzofitimod Fights Chronic Inflammation Stock Titan Wed, 12 Mar 2025 07:00:00 GMT
• aTyr Pharma’s efzofitimod shows promise in ILD treatment Investing.com Wed, 12 Mar 2025 07:00:00 GMT
• atyr pharma announces publication demonstrating efzofitimod’s immunomodulatory activity in science translational medicine The Globe and Mail Wed, 12 Mar 2025 07:00:00 GMT
• atyr pharma publishes efzofitimod data in science translational medicine TipRanks Wed, 12 Mar 2025 07:00:00 GMT
• atyr pharma shares rise after lung disease treatment passes safety review MarketWatch Fri, 07 Mar 2025 16:58:00 GMT
• atyr stock rises after update on lead program (atyr:nasdaq) Seeking Alpha Fri, 07 Mar 2025 12:50:00 GMT
• atyr pharma: attractive buy opportunity amid positive phase 2 data and anticipated phase 3 catalysts TipRanks Fri, 07 Mar 2025 08:00:00 GMT
• atyr pharma announces fourth positive dsmb review for efzofitimod in phase 3 efzo-fit™ study in pulmonary sarcoidosis The Manila Times Fri, 07 Mar 2025 08:00:00 GMT
• can this rare disease drug's perfect safety record signal a breakthrough for sarcoidosis patients? Stock Titan Thu, 06 Mar 2025 08:00:00 GMT
• atyr pharma (atyr) projected to post earnings on thursday Defense World Thu, 06 Mar 2025 08:00:00 GMT
• atyr pharma to webcast conference call reporting fourth quarter and full year end 2024 financial results GlobeNewswire Wed, 05 Mar 2025 01:38:46 GMT
• aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2024 Financial Results GlobeNewswire Tue, 04 Mar 2025 08:00:00 GMT
• When Will aTyr Pharma Reveal Its Latest Financial Performance? Date Now Set Stock Titan Tue, 04 Mar 2025 08:00:00 GMT
• positive outlook on atyr pharma: anticipated catalysts and risk-reward opportunities TipRanks Mon, 03 Mar 2025 07:41:15 GMT
• positive outlook on atyr pharma: anticipated catalysts and risk-reward opportunities TipRanks Sun, 02 Mar 2025 08:00:00 GMT
• aTyr Pharma Loses US$47m Market Value But Insiders See Windfall Of US$370k simplywall.st Fri, 28 Feb 2025 10:54:55 GMT
• d.a. davidson & co. takes $141,000 position in atyr pharma inc (nasdaq:atyr) Defense World Fri, 28 Feb 2025 08:00:00 GMT
• aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference GlobeNewswire Mon, 24 Feb 2025 08:00:00 GMT
• can atyr's pioneering trna platform transform fibrosis treatment? ceo to share latest insights Stock Titan Mon, 24 Feb 2025 08:00:00 GMT
• brokerages set atyr pharma inc (nasdaq:atyr) target price at $19.25 Defense World Fri, 21 Feb 2025 08:00:00 GMT
• atyr pharma inc (nasdaq:atyr) receives $19.25 average pt from brokerages MarketBeat Fri, 21 Feb 2025 06:36:34 GMT
• leerink partnrs upgrades atyr pharma (nasdaq:atyr) to strong-buy Defense World Thu, 20 Feb 2025 08:00:00 GMT
• short interest in atyr pharma inc (nasdaq:atyr) rises by 8.5% MarketBeat Thu, 20 Feb 2025 01:00:15 GMT
• atyr pharma inc (nasdaq:atyr) receives consensus recommendation of "buy" from brokerages MarketBeat Wed, 19 Feb 2025 13:34:01 GMT
• atyr pharma (nasdaq:atyr) earns outperform rating from analysts at leerink partners MarketBeat Wed, 19 Feb 2025 12:58:56 GMT
• atyr pharma (nasdaq:atyr) upgraded by leerink partnrs to "strong-buy" rating MarketBeat Wed, 19 Feb 2025 11:43:02 GMT
• Freedom Broker sets $9 target on aTyr Pharma, cites robust pipeline Investing.com Wed, 19 Feb 2025 08:00:00 GMT
• aTyr Pharma Stock Soars to 52-Week High of $4.22 Amidst Strong Growth Investing.com Wed, 19 Feb 2025 08:00:00 GMT
• atyr pharma (nasdaq:atyr) coverage initiated by analysts at leerink partners Defense World Wed, 19 Feb 2025 08:00:00 GMT
• atyr pharma inc (nasdaq:atyr) sees significant increase in short interest MarketBeat Wed, 19 Feb 2025 08:00:00 GMT
• cantor fitzgerald initiates coverage of atyr pharma (atyr) with overweight recommendation MSN Tue, 18 Feb 2025 22:49:36 GMT
• leerink partners initiates coverage on atyr pharma with outperform rating, $16 price target Marketscreener.com Tue, 18 Feb 2025 12:25:53 GMT
• Leerink Partners Initiates Coverage of aTyr Pharma (ATYR) with Outperform Recommendation Nasdaq Tue, 18 Feb 2025 08:00:00 GMT
• This aTyr Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday Benzinga Tue, 18 Feb 2025 08:00:00 GMT
• buy rating on atyr pharma driven by promising efzofitimod phase 3 study prospects TipRanks Tue, 18 Feb 2025 08:00:00 GMT
• short interest in atyr pharma inc (nasdaq:atyr) increases by 8.5% MarketBeat Mon, 17 Feb 2025 21:57:40 GMT
• atyr pharma inc (nasdaq:atyr) short interest up 8.5% in january MarketBeat Mon, 17 Feb 2025 21:57:40 GMT
• aTyr Pharma's SWOT analysis: efzofitimod's potential drives stock outlook Investing.com Mon, 17 Feb 2025 08:00:00 GMT
• a company insider recently sold 1,254 shares of atyr pharma inc [atyr]. should you sale? Knox Daily Thu, 13 Feb 2025 19:57:25 GMT
• atyr pharma inc (nasdaq: atyr): moving toward a higher share price Stocks Register Thu, 13 Feb 2025 16:03:03 GMT
• atyr pharma's swot analysis: efzofitimod's potential drives stock outlook MSN Thu, 13 Feb 2025 08:00:00 GMT
• financial health report: atyr pharma inc (atyr)’s ratios tell a tale The Dwinnex Wed, 12 Feb 2025 19:01:41 GMT
• now is the time to build a position in atyr pharma inc (nasdaq:atyr) Marketing Sentinel Sat, 08 Feb 2025 08:00:00 GMT
• stocks of atyr pharma inc (atyr) are poised to climb above their peers SETE News Thu, 06 Feb 2025 19:44:48 GMT
• recent insider activity suggests potential gains for atyr pharma inc (atyr) Knox Daily Wed, 05 Feb 2025 16:26:24 GMT
• how to interpret atyr pharma inc (atyr)’s stock chart patterns US Post News Wed, 05 Feb 2025 12:40:50 GMT
• atyr pharma cfo broadfoot sells $4,740 in stock by investing.com Investing.com Australia Wed, 05 Feb 2025 07:11:40 GMT
• atyr pharma's general counsel nancy denyes sells $3,398 in stock MSN Wed, 05 Feb 2025 01:25:45 GMT
• trading day review: atyr pharma inc (atyr) loses momentum, closing at 3.57 The Dwinnex Tue, 04 Feb 2025 16:41:07 GMT
• Atyr Pharma's general counsel Nancy Denyes sells $3,398 in stock Investing.com Tue, 04 Feb 2025 08:00:00 GMT
• jpmorgan chase & co. boosts holdings in atyr pharma inc (nasdaq:atyr) Defense World Tue, 04 Feb 2025 08:00:00 GMT
• atyr pharma cfo broadfoot sells $4,740 in stock by investing.com Investing.com Canada Tue, 04 Feb 2025 08:00:00 GMT
• short interest in atyr pharma inc (nasdaq:atyr) increases by 25.0% MarketBeat Tue, 04 Feb 2025 04:14:02 GMT
• short interest in atyr pharma inc (nasdaq:atyr) increases by 25.0% MarketBeat Mon, 03 Feb 2025 08:00:00 GMT
• atyr pharma inc (nasdaq:atyr) short interest up 25.0% in january MarketBeat Mon, 03 Feb 2025 03:41:01 GMT
• now is the time to build a position in atyr pharma inc (nasdaq:atyr) Marketing Sentinel Sun, 02 Feb 2025 04:28:16 GMT
• atyr pharma inc (nasdaq:atyr) short interest up 25.0% in january MarketBeat Sat, 01 Feb 2025 02:06:17 GMT
• head to head contrast: cero therapeutics (nasdaq:cero) versus atyr pharma (nasdaq:atyr) Defense World Fri, 31 Jan 2025 08:00:00 GMT
• Here's Why We're Watching aTyr Pharma's (NASDAQ:ATYR) Cash Burn Situation Yahoo Finance Thu, 30 Jan 2025 08:00:00 GMT
• aTyr Pharma to Present Three Posters for Efzofitimod at the GlobeNewswire Wed, 29 Jan 2025 08:00:00 GMT
• ATyr Pharma Advances Pulmonary Sarcoidosis Treatment With Efzofitimod At ATS 2025 Nasdaq Wed, 29 Jan 2025 08:00:00 GMT
• atyr pharma announces presentation of phase 3 efzo-fit™ study data and real-world evidence on pulmonary sarcoidosis at ats 2025 co... Nasdaq Wed, 29 Jan 2025 08:00:00 GMT
• revolutionary lung disease treatment shows promise: major updates coming at ats 2025 StockTitan Wed, 29 Jan 2025 08:00:00 GMT
aTyr Pharma, Inc(NASDAQ:LIFE) 
aTyr Pharma, Inc., a clinical stage biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead clinical product candidate is ATYR1923, a selective modulator of NRP2 for the treatment of patients with s...
Website: http://www.atyrpharma.com
Founded: 2005
Full Time Employees: 39
Sector: Healthcare
Industry: Biotechnology